Insights On Partnering

  1. Building A High-Quality IND From Scratch With Strategic Gap Analysis 8/12/2025

    A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).

  2. Meeting Eye Exam Needs At The Point Of Need 3/11/2025

    Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.

  3. Optimizing EDC Strategy And Data Collection for a Rare Disease Trial 6/11/2025

    Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.

  4. 2025 Clinical Trial Payment Tax Implications Explained 10/8/2025

    Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

  5. Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research 8/7/2024

    The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

  6. Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule 1/22/2026

    Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.

  7. How Automated Site Payment Solutions Are Revolutionizing Clinical Trials 8/16/2024

    Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.

  8. Flipping The Drug Development Industry On Its Head 6/18/2024

    The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

  9. Considerations For Subcutaneous, Intramuscular Formulation Development 8/7/2025

    Explore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.

  10. Australia's Edge In Oncology And Nuclear Medicine Trials 11/21/2025

    Discover how we leverage Australia’s world-class clinical infrastructure, streamlined regulatory environment, and early-phase expertise to accelerate oncology and nuclear medicine trials.